These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 30211828)
21. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432 [TBL] [Abstract][Full Text] [Related]
22. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546 [TBL] [Abstract][Full Text] [Related]
23. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275 [TBL] [Abstract][Full Text] [Related]
24. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis. Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897 [TBL] [Abstract][Full Text] [Related]
25. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence. Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055 [TBL] [Abstract][Full Text] [Related]
26. Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1 Makwana NB; Foley B; Lee S; Fernandez S; Irish AB; Price P Eur J Immunol; 2016 Nov; 46(11):2597-2608. PubMed ID: 27562679 [TBL] [Abstract][Full Text] [Related]
27. NKG2C Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334 [TBL] [Abstract][Full Text] [Related]
28. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026 [TBL] [Abstract][Full Text] [Related]
29. Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point. Alsulami K; Bolastig N; Dupuy FP; Mabanga T; Gilbert L; Kiani Z; Routy JP; Bruneau J; Thomas R; Tremblay C; Tsoukas CM; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Bernard NF; J Virol; 2021 Jul; 95(16):e0041721. PubMed ID: 34076484 [TBL] [Abstract][Full Text] [Related]
30. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. Djaoud Z; David G; Bressollette C; Willem C; Rettman P; Gagne K; Legrand N; Mehlal S; Cesbron A; Imbert-Marcille BM; Retière C J Immunol; 2013 Sep; 191(5):2708-16. PubMed ID: 23918974 [TBL] [Abstract][Full Text] [Related]
31. Spotlight on NKG2C and the human NK-cell response to CMV infection. Malmberg KJ; Beziat V; Ljunggren HG Eur J Immunol; 2012 Dec; 42(12):3141-5. PubMed ID: 23255011 [TBL] [Abstract][Full Text] [Related]
32. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis. Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E mBio; 2021 Mar; 12(2):. PubMed ID: 33727352 [TBL] [Abstract][Full Text] [Related]
33. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction. Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B Front Immunol; 2023; 14():1143875. PubMed ID: 37187736 [TBL] [Abstract][Full Text] [Related]
34. Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients. Achour A; Baychelier F; Besson C; Arnoux A; Marty M; Hannoun L; Samuel D; Debré P; Vieillard V; J Immunol; 2014 Jan; 192(1):503-11. PubMed ID: 24307732 [TBL] [Abstract][Full Text] [Related]
35. CXCR6 Aviles-Padilla K; Angelo LS; Fan D; Paust S Front Immunol; 2022; 13():886835. PubMed ID: 35844621 [TBL] [Abstract][Full Text] [Related]
36. HCMV-controlling NKG2C Bozzano F; Della Chiesa M; Pelosi A; Antonini F; Ascierto ML; Del Zotto G; Moretta F; Muccio L; Luganini A; Gribaudo G; Cenderello G; Dentone C; Nicolini L; Moretta A; Moretta L; De Maria A J Allergy Clin Immunol; 2021 Jun; 147(6):2343-2357. PubMed ID: 33493558 [TBL] [Abstract][Full Text] [Related]
37. Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients. Kawashima M; Ma J; Huszti E; Levy L; Berra G; Renaud-Picard B; Takahagi A; Ghany R; Sato M; Keshavjee S; Singer L; Husain S; Kumar D; Tikkanen J; Martinu T Am J Transplant; 2024 Jun; 24(6):1057-1069. PubMed ID: 38307417 [TBL] [Abstract][Full Text] [Related]
38. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Hadaya K; de Rham C; Bandelier C; Bandelier C; Ferrari-Lacraz S; Jendly S; Berney T; Buhler L; Kaiser L; Seebach JD; Tiercy JM; Martin PY; Villard J Am J Transplant; 2008 Dec; 8(12):2674-83. PubMed ID: 19032228 [TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C Comeau EM; Holder KA; Fudge NJ; Grant MD Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329 [TBL] [Abstract][Full Text] [Related]
40. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]